By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Caliper Life Sciences has completed the sales of its RapidTrace solid phase extraction and TurboVap evaporation product lines to Biotage for $16.5 million in cash.

The divestiture, announced a couple of weeks ago, also includes Biotage assuming liabilities of about $500,000 associated with the products.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.

Stanford University researchers are studying top athletes to uncover genes linked to performance.

The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.

Differences in DNA methylation could be used to distinguish between DNA samples obtained from identical twins, researchers say.